Anesthesia-related considerations for cerebral arteriovenous malformations.
In the optimum anesthetic management of patients with cerebral arteriovenous malformations (AVMs), the anesthesiologist should be familiar with the general pathophysiology of these lesions and various strategies for treatment. In this review, the authors outline these issues with special attention to cerebral hemodynamic changes induced by AVMs and their resection.
Hashimoto
T
T
Department of Anesthesia and Perioperative Care, Center for Cerebrovascular Research, University of California, San Francisco, California 94110, USA.
Young
W L
WL
D000768:Anesthesia, General / Q000379:methods*; D018681:Anesthetics, General / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D001925:Brain Damage, Chronic / Q000517:prevention & control; D001929:Brain Edema / Q000209:etiology / Q000517:prevention & control; D002543:Cerebral Hemorrhage / Q000209:etiology; D002560:Cerebrovascular Circulation / Q000187:drug effects; D000075202:Contraindications; D000077324:Crystalloid Solutions; D004573:Electrolytes / Q000008:administration & dosage; D005440:Fluid Therapy; D006801:Humans; D007022:Hypotension / Q000517:prevention & control; D007036:Hypothermia, Induced; D002538:Intracranial Arteriovenous Malformations / Q000150:complications / Q000503:physiopathology / Q000601:surgery*; D007431:Intraoperative Complications / Q000517:prevention & control; D007552:Isotonic Solutions; D016343:Monitoring, Intraoperative; D011182:Postoperative Care; D011183:Postoperative Complications / Q000517:prevention & control; D011187:Posture; D011300:Preoperative Care; D014665:Vasodilator Agents
D018681:Anesthetics, General; D000077324:Crystalloid Solutions; D004573:Electrolytes; D007552:Isotonic Solutions; D014665:Vasodilator Agents